{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:48:27Z","timestamp":1793166507203,"version":"4.5.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The development of therapeutic agonists for G protein-coupled receptors (GPCRs) is hampered by the propensity of GPCRs to couple to multiple intracellular signalling pathways. This promiscuous coupling leads to numerous downstream cellular effects, some of which are therapeutically undesirable. This is especially the case for adenosine A\n                    <jats:sub>1<\/jats:sub>\n                    receptors (A\n                    <jats:sub>1<\/jats:sub>\n                    Rs) whose clinical potential is undermined by the sedation and cardiorespiratory depression caused by conventional agonists. We have discovered that the A\n                    <jats:sub>1<\/jats:sub>\n                    R-selective agonist, benzyloxy-cyclopentyladenosine (BnOCPA), is a potent and powerful analgesic but does not cause sedation, bradycardia, hypotension or respiratory depression. This unprecedented discrimination between native A\n                    <jats:sub>1<\/jats:sub>\n                    Rs arises from BnOCPA\u2019s unique and exquisitely selective activation of Gob among the six G\u03b1i\/o subtypes, and in the absence of \u03b2-arrestin recruitment. BnOCPA thus demonstrates a highly-specific G\u03b1-selective activation of the native A\n                    <jats:sub>1<\/jats:sub>\n                    R, sheds new light on GPCR signalling, and reveals new possibilities for the development of novel therapeutics based on the far-reaching concept of selective G\u03b1 agonism.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31652-2","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:02:48Z","timestamp":1658116968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Selective activation of G\u03b1ob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-1867","authenticated-orcid":false,"given":"Mark J.","family":"Wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-8748","authenticated-orcid":false,"given":"Emily","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-3397","authenticated-orcid":false,"given":"Robert","family":"Huckstepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Barkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-2986","authenticated-orcid":false,"given":"Giuseppe","family":"Deganutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-4338","authenticated-orcid":false,"given":"Michele","family":"Leuenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Winfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Suchankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2260-3892","authenticated-orcid":false,"given":"Dewi","family":"Safitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7521-9969","authenticated-orcid":false,"given":"Wendy","family":"Imlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-4414","authenticated-orcid":false,"given":"Circe","family":"La Mache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherise","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-8173","authenticated-orcid":false,"given":"David","family":"Spanswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-5141","authenticated-orcid":false,"given":"Christopher A.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-1886","authenticated-orcid":false,"given":"Martin","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-9612","authenticated-orcid":false,"given":"Graham","family":"Ladds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-3172","authenticated-orcid":false,"given":"Bruno G.","family":"Frenguelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"31652_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schi\u00f6th, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"31652_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cell.2020.03.003","volume":"181","author":"M Congreve","year":"2020","unstructured":"Congreve, M., de Graaf, C., Swain, N. A. & Tate, C. G. Impact of GPCR structures on drug discovery. Cell 181, 81\u201391 (2020).","journal-title":"Cell"},{"key":"31652_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1124\/mol.117.111187","volume":"93","author":"T Kenakin","year":"2018","unstructured":"Kenakin, T. Is the quest for signaling bias worth the effort? Mol. Pharm. 93, 266\u2013269 (2018).","journal-title":"Mol. Pharm."},{"key":"31652_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1124\/mol.117.110890","volume":"93","author":"MC Michel","year":"2018","unstructured":"Michel, M. C. & Charlton, S. J. Biased agonism in drug discovery-is it too soon to choose a path? Mol. Pharm. 93, 259\u2013265 (2018).","journal-title":"Mol. Pharm."},{"key":"31652_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuropharm.2015.12.001","volume":"104","author":"KA Jacobson","year":"2016","unstructured":"Jacobson, K. A. & Muller, C. E. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology 104, 31\u201349 (2016).","journal-title":"Neuropharmacology"},{"key":"31652_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F. & Varani, K. Pharmacology of adenosine receptors: the state of the art. Physiol. Rev. 98, 1591\u20131625 (2018).","journal-title":"Physiol. Rev."},{"key":"31652_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.10.031","volume":"338","author":"J Sawynok","year":"2016","unstructured":"Sawynok, J. Adenosine receptor targets for pain. Neuroscience 338, 1\u201318 (2016).","journal-title":"Neuroscience"},{"key":"31652_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","volume":"140","author":"JP Headrick","year":"2013","unstructured":"Headrick, J. P., Ashton, K. J., Rose\u2019meyer, R. B. & Peart, J. N. Cardiovascular adenosine receptors: expression, actions and interactions. Pharm. Ther. 140, 92\u2013111 (2013).","journal-title":"Pharm. Ther."},{"key":"31652_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","volume":"24","author":"TV Dunwiddie","year":"2001","unstructured":"Dunwiddie, T. V. & Masino, S. A. The role and regulation of adenosine in the central nervous system. Annu Rev. Neurosci. 24, 31\u201355 (2001).","journal-title":"Annu Rev. Neurosci."},{"key":"31652_CR10","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1111\/bph.14337","volume":"175","author":"EA Vecchio","year":"2018","unstructured":"Vecchio, E. A. et al. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism. Br. J. Pharm. 175, 4036\u20134046 (2018).","journal-title":"Br. J. Pharm."},{"key":"31652_CR11","first-page":"759","volume":"59","author":"K Kaczynska","year":"2008","unstructured":"Kaczynska, K. & Szereda-Przestaszewska, M. The potential role of the nodose ganglion adenosine A1 receptor in regulation of breathing in anaesthetized rats. J. Physiol. Pharm. 59, 759\u2013770 (2008).","journal-title":"J. Physiol. Pharm."},{"key":"31652_CR12","doi-asserted-by":"publisher","first-page":"e6784","DOI":"10.1371\/journal.pone.0006784","volume":"4","author":"M Koeppen","year":"2009","unstructured":"Koeppen, M., Eckle, T. & Eltzschig, H. K. Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS ONE 4, e6784 (2009).","journal-title":"PLoS ONE"},{"key":"31652_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/5584_2017_61","volume":"1051","author":"K Varani","year":"2017","unstructured":"Varani, K., Vincenzi, F., Merighi, S., Gessi, S. & Borea, P. A. Biochemical and pharmacological role of A1 adenosine receptors and their modulation as novel therapeutic strategy. Adv. Exp. Med. Biol. 1051, 193\u2013232 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"31652_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bcp.2015.11.013","volume":"99","author":"JA Baltos","year":"2016","unstructured":"Baltos, J. A. et al. Quantification of adenosine A1 receptor biased agonism: Implications for drug discovery. Biochem. Pharm. 99, 101\u2013112 (2016).","journal-title":"Biochem. Pharm."},{"key":"31652_CR15","doi-asserted-by":"crossref","unstructured":"Weltha L., Reemmer J., Boison D. The role of adenosine in epilepsy. Brain Res. Bull. 151, 46\u201354 (2018).","DOI":"10.1016\/j.brainresbull.2018.11.008"},{"key":"31652_CR16","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.2174\/1381612825666190716100509","volume":"25","author":"PK Deb","year":"2019","unstructured":"Deb, P. K., Deka, S., Borah, P., Abed, S. N. & Klotz, K. N. Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: current status and perspectives. Curr. Pharm. Des. 25, 2697\u20132715 (2019).","journal-title":"Curr. Pharm. Des."},{"key":"31652_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1124\/pr.118.016790","volume":"71","author":"T Kenakin","year":"2019","unstructured":"Kenakin, T. Biased receptor signaling in drug discovery. Pharm. Rev. 71, 267\u2013315 (2019).","journal-title":"Pharm. Rev."},{"key":"31652_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","volume":"19","author":"D Wootten","year":"2018","unstructured":"Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M. & Sexton, P. M. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 19, 638\u2013653 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"31652_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","volume":"28","author":"JD Violin","year":"2007","unstructured":"Violin, J. D. & Lefkowitz, R. J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharm. Sci. 28, 416\u2013422 (2007).","journal-title":"Trends Pharm. Sci."},{"key":"31652_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrd.2017.229","volume":"17","author":"JS Smith","year":"2018","unstructured":"Smith, J. S., Lefkowitz, R. J. & Rajagopal, S. Biased signalling: from simple switches to allosteric microprocessors. Nat. Rev. Drug Discov. 17, 243\u2013260 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"31652_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuron.2017.03.016","volume":"94","author":"DJ Foster","year":"2017","unstructured":"Foster, D. J. & Conn, P. J. Allosteric modulation of GPCRs: new insights and potential utility for treatment of schizophrenia and other CNS disorders. Neuron 94, 431\u2013446 (2017).","journal-title":"Neuron"},{"key":"31652_CR22","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1126\/science.aay9813","volume":"367","author":"LM Wingler","year":"2020","unstructured":"Wingler, L. M. et al. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR. Science 367, 888\u2013892 (2020).","journal-title":"Science"},{"key":"31652_CR23","doi-asserted-by":"crossref","unstructured":"Slosky L. M., et al. Beta-arrestin-biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors. Cell 181, 1364\u20131379.e14 (2020).","DOI":"10.1016\/j.cell.2020.04.053"},{"key":"31652_CR24","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1111\/bph.15004","volume":"177","author":"A Kliewer","year":"2020","unstructured":"Kliewer, A. et al. Morphine-induced respiratory depression is independent of beta-arrestin2 signalling. Br. J. Pharm. 177, 2923\u20132931 (2020).","journal-title":"Br. J. Pharm."},{"key":"31652_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02606-w","volume":"9","author":"H Yano","year":"2018","unstructured":"Yano, H. et al. Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor. Nat. Commun. 9, 486 (2018).","journal-title":"Nat. Commun."},{"key":"31652_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.chembiol.2021.07.004","volume":"29","author":"E Von Moo","year":"2022","unstructured":"Von Moo, E. et al. Ligand-directed bias of G protein signaling at the dopamine D2 receptor. Cell Chem. Biol. 29, 226\u2013238.e224 (2022).","journal-title":"Cell Chem. Biol."},{"key":"31652_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cellsig.2017.05.002","volume":"41","author":"LM Luttrell","year":"2018","unstructured":"Luttrell, L. M., Maudsley, S. & Gesty-Palmer, D. Translating in vitro ligand bias into in vivo efficacy. Cell Signal. 41, 46\u201355 (2018).","journal-title":"Cell Signal."},{"key":"31652_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11875-6","volume":"10","author":"B Benredjem","year":"2019","unstructured":"Benredjem, B. et al. Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response. Nat. Commun. 10, 4075 (2019).","journal-title":"Nat. Commun."},{"key":"31652_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.bjp.0705925","volume":"143","author":"Y Cordeaux","year":"2004","unstructured":"Cordeaux, Y., Ijzerman, A. P. & Hill, S. J. Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Br. J. Pharm. 143, 705\u2013714 (2004).","journal-title":"Br. J. Pharm."},{"key":"31652_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1124\/jpet.109.158667","volume":"331","author":"GD Stewart","year":"2009","unstructured":"Stewart, G. D. et al. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity. J. Pharm. Exp. Ther. 331, 277\u2013286 (2009).","journal-title":"J. Pharm. Exp. Ther."},{"key":"31652_CR31","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1073\/pnas.1320962111","volume":"111","author":"C Valant","year":"2014","unstructured":"Valant, C. et al. Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist. Proc. Natl Acad. Sci. USA 111, 4614\u20134619 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31652_CR32","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1021\/acs.jmedchem.8b00047","volume":"61","author":"L Aurelio","year":"2018","unstructured":"Aurelio, L. et al. A Structure-Activity Relationship Study of Bitopic N(6)-Substituted Adenosine Derivatives as Biased Adenosine A1 Receptor Agonists. J. Med Chem. 61, 2087\u20132103 (2018).","journal-title":"J. Med Chem."},{"key":"31652_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1021\/acs.jmedchem.5b01402","volume":"59","author":"A Knight","year":"2016","unstructured":"Knight, A. et al. Discovery of novel adenosine receptor agonists that exhibit subtype selectivity. J. Med Chem. 59, 947\u2013964 (2016).","journal-title":"J. Med Chem."},{"key":"31652_CR34","unstructured":"Jagtap P. Adenosine compounds and their use thereof Patent WO2011\/119919 A1 (2011)."},{"key":"31652_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1358\/dof.1995.020.07.531583","volume":"20","author":"KA Jacobson","year":"1995","unstructured":"Jacobson, K. A. et al. A3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20, 689\u2013699 (1995).","journal-title":"Drugs Future"},{"key":"31652_CR36","first-page":"3684","volume":"97","author":"S Angers","year":"2000","unstructured":"Angers, S. et al. Detection of \u03b22-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl Acad. Sci. 97, 3684\u20133689 (2000).","journal-title":"Proc. Natl Acad. Sci."},{"key":"31652_CR37","doi-asserted-by":"crossref","unstructured":"Hamdan F. F., Percherancier Y., Breton B., Bouvier M. Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET). Curr Protoc Neurosci Chapter 5, Unit 5.23 (2006).","DOI":"10.1002\/0471142301.ns0523s34"},{"key":"31652_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-1-61779-126-0_20","volume":"746","author":"M Kocan","year":"2011","unstructured":"Kocan, M. & Pfleger, K. D. Study of GPCR-protein interactions by BRET. Methods Mol. Biol. 746, 357\u2013371 (2011).","journal-title":"Methods Mol. Biol."},{"key":"31652_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nprot.2006.52","volume":"1","author":"KD Pfleger","year":"2006","unstructured":"Pfleger, K. D., Seeber, R. M. & Eidne, K. A. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat. Protoc. 1, 337\u2013345 (2006).","journal-title":"Nat. Protoc."},{"key":"31652_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fendo.2012.00105","volume":"3","author":"A Salahpour","year":"2012","unstructured":"Salahpour, A. et al. BRET biosensors to study GPCR biology, pharmacology, and signal transduction. Front Endocrinol. (Lausanne) 3, 105 (2012).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"31652_CR41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1124\/mol.52.5.788","volume":"52","author":"F Ciruela","year":"1997","unstructured":"Ciruela, F. et al. Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. Mol. Pharm. 52, 788\u2013797 (1997).","journal-title":"Mol. Pharm."},{"key":"31652_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0014-4827(02)00090-3","volume":"285","author":"M Escriche","year":"2003","unstructured":"Escriche, M. et al. Ligand-induced caveolae-mediated internalization of A1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Exp. Cell Res. 285, 72\u201390 (2003).","journal-title":"Exp. Cell Res."},{"key":"31652_CR43","doi-asserted-by":"publisher","first-page":"14748","DOI":"10.1021\/bi0262911","volume":"41","author":"G Ferguson","year":"2002","unstructured":"Ferguson, G., Watterson, K. R. & Palmer, T. M. Subtype-specific regulation of receptor internalization and recycling by the carboxyl-terminal domains of the human A1 and rat A3 adenosine receptors: consequences for agonist-stimulated translocation of arrestin3. Biochemistry 41, 14748\u201314761 (2002).","journal-title":"Biochemistry"},{"key":"31652_CR44","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1124\/mol.59.5.1314","volume":"59","author":"S Gines","year":"2001","unstructured":"Gines, S. et al. Involvement of caveolin in ligand-induced recruitment and internalization of A1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol. Pharm. 59, 1314\u20131323 (2001).","journal-title":"Mol. Pharm."},{"key":"31652_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/mol.56.2.316","volume":"56","author":"L Iacovelli","year":"1999","unstructured":"Iacovelli, L., Franchetti, R., Grisolia, D. & De Blasi, A. Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha1B-adrenergic, and A1 adenosine receptor-mediated responses. Mol. Pharm. 56, 316\u2013324 (1999).","journal-title":"Mol. Pharm."},{"key":"31652_CR46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41422-019-0256-2","volume":"29","author":"W Yin","year":"2019","unstructured":"Yin, W. et al. A complex structure of arrestin-2 bound to a G protein-coupled receptor. Cell Res. 29, 971\u2013983 (2019).","journal-title":"Cell Res."},{"key":"31652_CR47","unstructured":"Evans B. Adenosine Derivatives Patent EP0322242 (1989)."},{"key":"31652_CR48","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1476-5381.1993.tb13629.x","volume":"109","author":"MF Gurden","year":"1993","unstructured":"Gurden, M. F. et al. Functional characterization of three adenosine receptor types. Br. J. Pharm. 109, 693\u2013698 (1993).","journal-title":"Br. J. Pharm."},{"key":"31652_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1042\/cs0840663","volume":"84","author":"P Strong","year":"1993","unstructured":"Strong, P. et al. Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236. Clin. Sci. (Lond.) 84, 663\u2013669 (1993).","journal-title":"Clin. Sci. (Lond.)"},{"key":"31652_CR50","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1021\/bi982054f","volume":"38","author":"A Wise","year":"1999","unstructured":"Wise, A., Sheehan, M., Rees, S., Lee, M. & Milligan, G. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi\/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi\/o alpha fusion proteins. Biochemistry 38, 2272\u20132278 (1999).","journal-title":"Biochemistry"},{"key":"31652_CR51","doi-asserted-by":"crossref","unstructured":"Avet C., et al. Selectivity landscape of 100 therapeutically relevant GPCR profiled by an effector translocation-based BRET platform. bioRxiv, https:\/\/www.biorxiv.org\/content\/10.1101\/2020.04.20.052027v1 (2020).","DOI":"10.2139\/ssrn.3586569"},{"key":"31652_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","volume":"220","author":"JW Black","year":"1983","unstructured":"Black, J. W. & Leff, P. Operational models of pharmacological agonism. Proc. R. Soc. Lond. B Biol. Sci. 220, 141\u2013162 (1983).","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"31652_CR53","doi-asserted-by":"publisher","first-page":"11820","DOI":"10.1073\/pnas.2000712117","volume":"117","author":"I Gomes","year":"2020","unstructured":"Gomes, I. et al. Biased signaling by endogenous opioid peptides. Proc. Natl Acad. Sci. USA 117, 11820\u201311828 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31652_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1021\/cn200111m","volume":"3","author":"T Kenakin","year":"2012","unstructured":"Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A. & Novick, S. A simple method for quantifying functional selectivity and agonist bias. ACS Chem. Neurosci. 3, 193\u2013203 (2012).","journal-title":"ACS Chem. Neurosci."},{"key":"31652_CR55","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"31652_CR56","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nsmb1134","volume":"13","author":"C Gal\u00e9s","year":"2006","unstructured":"Gal\u00e9s, C. et al. Probing the activation-promoted structural rearrangements in preassembled receptor\u2013G protein complexes. Nat. Struct. Mol. Biol. 13, 778\u2013786 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"31652_CR57","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1074\/jbc.M111.277178","volume":"287","author":"M Busnelli","year":"2012","unstructured":"Busnelli, M. et al. Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J. Biol. Chem. 287, 3617\u20133629 (2012).","journal-title":"J. Biol. Chem."},{"key":"31652_CR58","doi-asserted-by":"crossref","unstructured":"Tallarida R. J., Murray R. B. Analysis of the Regression Line. In: Manual of Pharmacologic Calculations: With Computer Programs). Springer New York (1987).","DOI":"10.1007\/978-1-4612-4974-0_6"},{"key":"31652_CR59","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1006\/exnr.1999.7312","volume":"161","author":"K Kolasa","year":"2000","unstructured":"Kolasa, K., Harrell, L. E. & Parsons, D. S. Effects of pertussis toxin and galpha-protein-specific antibodies on phosphoinositide hydrolysis in rat brain membranes after cholinergic denervation and hippocampal sympathetic ingrowth. Exp. Neurol. 161, 724\u2013732 (2000).","journal-title":"Exp. Neurol."},{"key":"31652_CR60","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/stke.2002.118.pl1","volume":"2002","author":"A Gilchrist","year":"2002","unstructured":"Gilchrist, A., Li, A. & Hamm, H. E. G alpha COOH-terminal minigene vectors dissect heterotrimeric G protein signaling. Sci. STKE 2002, pl1 (2002).","journal-title":"Sci. STKE"},{"key":"31652_CR61","doi-asserted-by":"crossref","unstructured":"Gilchrist A., et al. Antagonists of the receptor-G protein interface block Gi-coupled signal transduction. J. Biol. Chem. 273, 14912\u201314919 (1998).","DOI":"10.1074\/jbc.273.24.14912"},{"key":"31652_CR62","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1523\/JNEUROSCI.0516-18.2018","volume":"38","author":"KB McPherson","year":"2018","unstructured":"McPherson, K. B. et al. Regulators of G-protein signaling (RGS) proteins promote receptor coupling to G-protein-coupled inwardly rectifying potassium (GIRK) channels. J. Neurosci. 38, 8737\u20138744 (2018).","journal-title":"J. Neurosci."},{"key":"31652_CR63","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nn1700","volume":"9","author":"J Ding","year":"2006","unstructured":"Ding, J. et al. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat. Neurosci. 9, 832\u2013842 (2006).","journal-title":"Nat. Neurosci."},{"key":"31652_CR64","doi-asserted-by":"publisher","first-page":"34143","DOI":"10.1074\/jbc.M204477200","volume":"277","author":"JF Vanhauwe","year":"2002","unstructured":"Vanhauwe, J. F. et al. Thrombin receptors activate Go proteins in endothelial cells to regulate intracellular calcium and cell shape changes. J. Biol. Chem. 277, 34143\u201334149 (2002).","journal-title":"J. Biol. Chem."},{"key":"31652_CR65","doi-asserted-by":"crossref","unstructured":"Goldsmith P., et al. Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J. Biol. Chem. 262, 14683\u201314688 (1987).","DOI":"10.1016\/S0021-9258(18)47849-0"},{"key":"31652_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0165-2478(90)90207-7","volume":"25","author":"M Mousli","year":"1990","unstructured":"Mousli, M., Bronner, C., Bockaert, J., Rouot, B. & Landry, Y. Interaction of substance P, compound 48\/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol. Lett. 25, 355\u2013357 (1990).","journal-title":"Immunol. Lett."},{"key":"31652_CR67","doi-asserted-by":"publisher","first-page":"33135","DOI":"10.1074\/jbc.273.50.33135","volume":"273","author":"WE McIntire","year":"1998","unstructured":"McIntire, W. E., Dingus, J., Schey, K. L. & Hildebrandt, J. D. Characterization of the major bovine brain Go alpha isoforms. Mapping the structural differences between the alpha subunit isoforms identifies a variable region of the protein involved in receptor interactions. J. Biol. Chem. 273, 33135\u201333141 (1998).","journal-title":"J. Biol. Chem."},{"key":"31652_CR68","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1152\/jn.1995.74.5.2189","volume":"74","author":"S Oleskevich","year":"1995","unstructured":"Oleskevich, S. G alpha o1 decapeptide modulates the hippocampal 5-HT1A potassium current. J. Neurophysiol. 74, 2189\u20132193 (1995).","journal-title":"J. Neurophysiol."},{"key":"31652_CR69","first-page":"273","volume":"41","author":"B Rouot","year":"1992","unstructured":"Rouot, B. et al. Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation. Mol. Pharm. 41, 273\u2013280 (1992).","journal-title":"Mol. Pharm."},{"key":"31652_CR70","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/00001756-200506210-00009","volume":"16","author":"S Oleskevich","year":"2005","unstructured":"Oleskevich, S., Leck, K. J., Matthaei, K. & Hendry, I. A. Enhanced serotonin response in the hippocampus of Galphaz protein knock-out mice. Neuroreport 16, 921\u2013925 (2005).","journal-title":"Neuroreport"},{"key":"31652_CR71","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1021\/acsptsci.0c00195","volume":"4","author":"G Deganutti","year":"2021","unstructured":"Deganutti, G. et al. Deciphering the agonist binding mechanism to the adenosine A1. Receptor. ACS Pharm. Transl. Sci. 4, 314\u2013326 (2021).","journal-title":"Receptor. ACS Pharm. Transl. Sci."},{"key":"31652_CR72","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.str.2017.06.012","volume":"25","author":"RKY Cheng","year":"2017","unstructured":"Cheng, R. K. Y. et al. Structures of human A1 and A2A adenosine receptors with xanthines reveal determinants of selectivity. Structure 25, 1275\u20131285.e1274 (2017).","journal-title":"Structure"},{"key":"31652_CR73","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s42254-020-0153-0","volume":"2","author":"G Bussi","year":"2020","unstructured":"Bussi, G. & Laio, A. Using metadynamics to explore complex free-energy landscapes. Nat. Rev. Phys. 2, 200\u2013212 (2020).","journal-title":"Nat. Rev. Phys."},{"key":"31652_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature22070","volume":"545","author":"T Flock","year":"2017","unstructured":"Flock, T. et al. Selectivity determinants of GPCR-G-protein binding. Nature 545, 317\u2013322 (2017).","journal-title":"Nature"},{"key":"31652_CR75","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.1073\/pnas.1905993116","volume":"116","author":"N Okashah","year":"2019","unstructured":"Okashah, N. et al. Variable G protein determinants of GPCR coupling selectivity. Proc. Natl Acad. Sci. USA 116, 12054\u201312059 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31652_CR76","doi-asserted-by":"publisher","first-page":"18684","DOI":"10.1073\/pnas.1110499108","volume":"108","author":"RO Dror","year":"2011","unstructured":"Dror, R. O. et al. Activation mechanism of the \u03b22-adrenergic receptor. Proc. Natl. Acad. Sci. USA 108, 18684\u201318689 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"31652_CR77","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41586-018-0236-6","volume":"558","author":"CJ Draper-Joyce","year":"2018","unstructured":"Draper-Joyce, C. J. et al. Structure of the adenosine-bound human adenosine A1 receptor-Gi complex. Nature 558, 559\u2013563 (2018).","journal-title":"Nature"},{"key":"31652_CR78","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2017.01.042","volume":"168","author":"A Glukhova","year":"2017","unstructured":"Glukhova, A. et al. Structure of the adenosine A1 receptor reveals the basis for subtype selectivity. Cell 168, 867\u2013877 e813 (2017).","journal-title":"Cell"},{"key":"31652_CR79","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature08144","volume":"459","author":"DM Rosenbaum","year":"2009","unstructured":"Rosenbaum, D. M., Rasmussen, S. G. & Kobilka, B. K. The structure and function of G-protein-coupled receptors. Nature 459, 356\u2013363 (2009).","journal-title":"Nature"},{"key":"31652_CR80","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41586-019-1337-6","volume":"572","author":"HE Kato","year":"2019","unstructured":"Kato, H. E. et al. Conformational transitions of a neurotensin receptor 1-Gi1 complex. Nature 572, 80\u201385 (2019).","journal-title":"Nature"},{"key":"31652_CR81","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2019.04.021","volume":"177","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Structural insights into the process of GPCR-G protein complex formation. Cell 177, 1243\u20131251 e1212 (2019).","journal-title":"Cell"},{"key":"31652_CR82","doi-asserted-by":"publisher","first-page":"D335","DOI":"10.1093\/nar\/gkaa1080","volume":"49","author":"AJ Kooistra","year":"2020","unstructured":"Kooistra, A. J. et al. GPCRdb in 2021: integrating GPCR sequence, structure and function. Nucleic Acids Res. 49, D335\u2013D343 (2020).","journal-title":"Nucleic Acids Res."},{"key":"31652_CR83","unstructured":"GPCRdb. Human A1R mutations. https:\/\/gpcrdb.org\/mutations\/protein\/aa1r_human\/ (2020)."},{"key":"31652_CR84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/oxfordjournals.jbchem.a124707","volume":"117","author":"T Asano","year":"1995","unstructured":"Asano, T. et al. The G-protein Go in mammalian cardiac muscle: localization and coupling to A1 adenosine receptors. J. Biochem 117, 183\u2013189 (1995).","journal-title":"J. Biochem"},{"key":"31652_CR85","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1006\/jmcc.1998.0679","volume":"30","author":"WP Wolf","year":"1998","unstructured":"Wolf, W. P., Spicher, K., Haase, H. & Schulze, W. Immunocytochemical localization of the G-protein sub-unit, Go alpha, in rat heart. Implications for a role of Go alpha in secretion of cardiac hormones. J. Mol. Cell Cardiol. 30, 1149\u20131162 (1998).","journal-title":"J. Mol. Cell Cardiol."},{"key":"31652_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-254","volume":"10","author":"MF McGrath","year":"2009","unstructured":"McGrath, M. F. & de Bold, A. J. Transcriptional analysis of the mammalian heart with special reference to its endocrine function. BMC Genomics 10, 254 (2009).","journal-title":"BMC Genomics"},{"key":"31652_CR87","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000186688","volume":"17","author":"M Jiang","year":"2009","unstructured":"Jiang, M. & Bajpayee, N. S. Molecular mechanisms of Go signaling. Neurosignals 17, 23\u201341 (2009).","journal-title":"Neurosignals"},{"key":"31652_CR88","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1006\/jmcc.1996.0146","volume":"28","author":"Y Kawai","year":"1996","unstructured":"Kawai, Y. & Arinze, I. J. Differential localization and development-dependent expression of G-protein subunits, Go alpha and G beta, in rabbit heart. J. Mol. Cell Cardiol. 28, 1555\u20131564 (1996).","journal-title":"J. Mol. Cell Cardiol."},{"key":"31652_CR89","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1096\/fasebj.9.5.7896004","volume":"9","author":"L Belardinelli","year":"1995","unstructured":"Belardinelli, L., Shryock, J. C., Song, Y., Wang, D. & Srinivas, M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J. 9, 359\u2013365 (1995).","journal-title":"FASEB J."},{"key":"31652_CR90","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","volume":"50","author":"SH Kim","year":"1992","unstructured":"Kim, S. H. & Chung, J. M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355\u2013363 (1992).","journal-title":"Pain"},{"key":"31652_CR91","doi-asserted-by":"publisher","first-page":"e010364","DOI":"10.1136\/bmjopen-2015-010364","volume":"6","author":"A Fayaz","year":"2016","unstructured":"Fayaz, A., Croft, P., Langford, R. M., Donaldson, L. J. & Jones, G. T. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open 6, e010364 (2016).","journal-title":"BMJ Open"},{"key":"31652_CR92","doi-asserted-by":"crossref","unstructured":"Yong R. J., Mullins P. M., Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain 163, e328\u2013e332 (2021).","DOI":"10.1097\/j.pain.0000000000002291"},{"key":"31652_CR93","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos, T. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1211\u20131259 (2017).","journal-title":"Lancet"},{"key":"31652_CR94","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.bja.2018.02.066","volume":"120","author":"M Chincholkar","year":"2018","unstructured":"Chincholkar, M. Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review. Br. J. Anaesth. 120, 1315\u20131334 (2018).","journal-title":"Br. J. Anaesth."},{"key":"31652_CR95","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/jm980093j","volume":"41","author":"AH Li","year":"1998","unstructured":"Li, A. H., Moro, S., Melman, N., Ji, X. D. & Jacobson, K. A. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J. Med. Chem. 41, 3186\u20133201 (1998).","journal-title":"J. Med. Chem."},{"key":"31652_CR96","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","volume":"11","author":"MW Alnouri","year":"2015","unstructured":"Alnouri, M. W. et al. Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal 11, 389\u2013407 (2015).","journal-title":"Purinergic Signal"},{"key":"31652_CR97","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1096\/fj.11-201541","volume":"26","author":"Z Chen","year":"2012","unstructured":"Chen, Z. et al. Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J. 26, 1855\u20131865 (2012).","journal-title":"FASEB J."},{"key":"31652_CR98","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1523\/JNEUROSCI.4495-14.2015","volume":"35","author":"A Ford","year":"2015","unstructured":"Ford, A. et al. Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain. J. Neurosci. 35, 6057\u20136067 (2015).","journal-title":"J. Neurosci."},{"key":"31652_CR99","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1097\/j.pain.0000000000001905","volume":"161","author":"E Lucarini","year":"2020","unstructured":"Lucarini, E. et al. Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels. Pain 161, 2179\u20132190 (2020).","journal-title":"Pain"},{"key":"31652_CR100","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1124\/mol.115.099499","volume":"88","author":"WL Imlach","year":"2015","unstructured":"Imlach, W. L., Bhola, R. F., May, L. T., Christopoulos, A. & Christie, M. J. A positive allosteric modulator of the adenosine A1 receptor selectively inhibits primary afferent synaptic transmission in a neuropathic pain model. Mol. Pharm. 88, 460\u2013468 (2015).","journal-title":"Mol. Pharm."},{"key":"31652_CR101","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/brain\/awu330","volume":"138","author":"JW Little","year":"2015","unstructured":"Little, J. W. et al. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Brain 138, 28\u201335 (2015).","journal-title":"Brain"},{"key":"31652_CR102","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1523\/JNEUROSCI.17-02-00607.1997","volume":"17","author":"TV Dunwiddie","year":"1997","unstructured":"Dunwiddie, T. V., Diao, L., Kim, H. O., Jiang, J. L. & Jacobson, K. A. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J. Neurosci. 17, 607\u2013614 (1997).","journal-title":"J. Neurosci."},{"key":"31652_CR103","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1517\/13543784.2012.719873","volume":"21","author":"JR Colca","year":"2012","unstructured":"Colca, J. R. Discontinued drugs 2011: endocrine and metabolic. Expert Opin. Investig. Drugs 21, 1619\u20131624 (2012).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"31652_CR104","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/jpet.105.099119","volume":"317","author":"M Fatholahi","year":"2006","unstructured":"Fatholahi, M. et al. A novel partial agonist of the A1 adenosine receptor and evidence of receptor homogeneity in adipocytes. J. Pharmacol. Exp. Ther. 317, 676\u2013684 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"31652_CR105","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","volume":"68","author":"AN Drury","year":"1929","unstructured":"Drury, A. N. & Szent-Gyorgyi, A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. 68, 213\u2013237 (1929).","journal-title":"J. Physiol."},{"key":"31652_CR106","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1097\/j.pain.0000000000001340","volume":"159","author":"NB Finnerup","year":"2018","unstructured":"Finnerup, N. B. et al. Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy. Pain 159, 2339\u20132346 (2018).","journal-title":"Pain"},{"key":"31652_CR107","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuropharm.2017.12.032","volume":"131","author":"MZ Imam","year":"2018","unstructured":"Imam, M. Z., Kuo, A., Ghassabian, S. & Smith, M. T. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Neuropharmacology 131, 238\u2013255 (2018).","journal-title":"Neuropharmacology"},{"key":"31652_CR108","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1113\/jphysiol.2013.253450","volume":"591","author":"MJ Wall","year":"2013","unstructured":"Wall, M. J. & Dale, N. Neuronal transporter and astrocytic ATP exocytosis underlie activity-dependent adenosine release in the hippocampus. J. Physiol. 591, 3853\u20133871 (2013).","journal-title":"J. Physiol."},{"key":"31652_CR109","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jneumeth.2006.12.018","volume":"162","author":"WW Anderson","year":"2007","unstructured":"Anderson, W. W. & Collingridge, G. L. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J. Neurosci. Methods 162, 346\u2013356 (2007).","journal-title":"J. Neurosci. Methods"},{"key":"31652_CR110","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jneumeth.2015.09.011","volume":"260","author":"BG Frenguelli","year":"2016","unstructured":"Frenguelli, B. G. & Wall, M. J. Combined electrophysiological and biosensor approaches to study purinergic regulation of epileptiform activity in cortical tissue. J. Neurosci. Methods 260, 202\u2013214 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"31652_CR111","doi-asserted-by":"publisher","first-page":"25763","DOI":"10.1074\/jbc.A116.751362","volume":"291","author":"C Weston","year":"2016","unstructured":"Weston, C. et al. Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors. J. Biol. Chem. 291, 25763 (2016).","journal-title":"J. Biol. Chem."},{"key":"31652_CR112","doi-asserted-by":"crossref","unstructured":"Barkan, K. et al. Pharmacological characterisation of novel adenosine receptor A3R antagonists. Sci. Rep. 27, 20781 (2019).","DOI":"10.1101\/693796"},{"key":"31652_CR113","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.chembiol.2012.07.014","volume":"19","author":"LA Stoddart","year":"2012","unstructured":"Stoddart, L. A. et al. Fragment screening at adenosine-A3\u00a0receptors in living cells using a fluorescence-based binding assay. Chem. Biol. 19, 1105\u20131115 (2012).","journal-title":"Chem. Biol."},{"key":"31652_CR114","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1021\/jm201722y","volume":"55","author":"AJ Vernall","year":"2012","unstructured":"Vernall, A. J., Stoddart, L. A., Briddon, S. J., Hill, S. J. & Kellam, B. Highly potent and selective fluorescent antagonists of the human adenosine A3\u00a0receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold. J. Med. Chem. 55, 1771\u20131782 (2012).","journal-title":"J. Med. Chem."},{"key":"31652_CR115","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nmeth.3398","volume":"12","author":"LA Stoddart","year":"2015","unstructured":"Stoddart, L. A. et al. Application of BRET to monitor ligand binding to GPCRs. Nat. Methods 12, 661\u2013663 (2015).","journal-title":"Nat. Methods"},{"key":"31652_CR116","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & MacKerell, A. D. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135\u20132145 (2013).","journal-title":"J. Comput. Chem."},{"key":"31652_CR117","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"31652_CR118","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Jr. Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"31652_CR119","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ci3003649","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K., Raman, E. P. & MacKerell, A. D. Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J. Chem. Inf. Model. 52, 3155\u20133168 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"31652_CR120","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcc.23067","volume":"33","author":"W Yu","year":"2012","unstructured":"Yu, W., He, X., Vanommeslaeghe, K. & MacKerell, A. D. Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. J. Comput. Chem. 33, 2451\u20132468 (2012).","journal-title":"J. Comput. Chem."},{"key":"31652_CR121","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","volume":"12","author":"S Doerr","year":"2016","unstructured":"Doerr, S., Harvey, M. J., No\u00e9, F. & De Fabritiis, G. HTMD: high-throughput molecular dynamics for molecular discovery. J. Chem. Theory Comput. 12, 1845\u20131852 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"31652_CR122","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph 14, 33\u201338 (1996). 27-38.","journal-title":"J. Mol. Graph"},{"key":"31652_CR123","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/jcc.23422","volume":"34","author":"CG Mayne","year":"2013","unstructured":"Mayne, C. G., Saam, J., Schulten, K., Tajkhorshid, E. & Gumbart, J. C. Rapid parameterization of small molecules using the Force Field Toolkit. J. Comput Chem. 34, 2757\u20132770 (2013).","journal-title":"J. Comput Chem."},{"key":"31652_CR124","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nsb1203-980","volume":"10","author":"H Berman","year":"2003","unstructured":"Berman, H., Henrick, K. & Nakamura, H. Announcing the worldwide Protein Data bank. Nat. Struct. Biol. 10, 980 (2003).","journal-title":"Nat. Struct. Biol."},{"key":"31652_CR125","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res"},{"key":"31652_CR126","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","volume":"374","author":"A Fiser","year":"2003","unstructured":"Fiser, A. & Sali, A. Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol. 374, 461\u2013491 (2003).","journal-title":"Methods Enzymol."},{"key":"31652_CR127","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779\u2013815 (1993).","journal-title":"J. Mol. Biol."},{"key":"31652_CR128","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bcp.2018.02.005","volume":"150","author":"E Dal Maso","year":"2018","unstructured":"Dal Maso, E. et al. Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy. Biochem. Pharmacol. 150, 214\u2013244 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"31652_CR129","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-018-0535-y","volume":"561","author":"Y-L Liang","year":"2018","unstructured":"Liang, Y.-L. et al. Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor. Nature 561, 492\u2013497 (2018).","journal-title":"Nature"},{"key":"31652_CR130","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665\u2013667 (2004).","journal-title":"Nucleic Acids Res."},{"key":"31652_CR131","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson, M. H. M., S\u00f8ndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: consistent treatment of internal and surface residues in empirical pK predictions. J. Chem. Theory Comput 7, 525\u2013537 (2011).","journal-title":"J. Chem. Theory Comput"},{"key":"31652_CR132","doi-asserted-by":"publisher","first-page":"e201302014","DOI":"10.5936\/csbj.201302014","volume":"5","author":"B Sommer","year":"2013","unstructured":"Sommer, B. Membrane packing problems: a short review on computational membrane modeling methods and tools. Comput Struct. Biotechnol. J. 5, e201302014 (2013).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"31652_CR133","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","volume":"22","author":"MA Lomize","year":"2006","unstructured":"Lomize, M. A., Lomize, A. L., Pogozheva, I. D. & Mosberg, H. I. OPM: orientations of proteins in membranes database. Bioinformatics 22, 623\u2013625 (2006).","journal-title":"Bioinformatics"},{"key":"31652_CR134","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926 (1983).","journal-title":"J. Chem. Phys."},{"key":"31652_CR135","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1021\/ct9000685","volume":"5","author":"MJ Harvey","year":"2009","unstructured":"Harvey, M. J., Giupponi, G. & Fabritiis, G. D. ACEMD: accelerating biomolecular dynamics in the microsecond time scale. J. Chem. Theory Comput. 5, 1632\u20131639 (2009).","journal-title":"J. Chem. Theory Comput."},{"key":"31652_CR136","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684 (1984).","journal-title":"J. Chem. Phys."},{"key":"31652_CR137","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/bip.360320508","volume":"32","author":"RJ Loncharich","year":"1992","unstructured":"Loncharich, R. J., Brooks, B. R. & Pastor, R. W. Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N\u2019-methylamide. Biopolymers 32, 523\u2013535 (1992).","journal-title":"Biopolymers"},{"key":"31652_CR138","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4155\/fmc-2016-0224","volume":"9","author":"G Deganutti","year":"2017","unstructured":"Deganutti, G. & Moro, S. Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategies. Future Med. Chem. 9, 507\u2013523 (2017).","journal-title":"Future Med. Chem."},{"key":"31652_CR139","doi-asserted-by":"crossref","unstructured":"Sabbadin D., Salmaso V., Sturlese M., Moro S. Supervised molecular dynamics (sumd) approaches in drug design 1824:287\u2013298 (2018).","DOI":"10.1007\/978-1-4939-8630-9_17"},{"key":"31652_CR140","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/acs.jcim.5b00702","volume":"56","author":"A Cuzzolin","year":"2016","unstructured":"Cuzzolin, A. et al. Deciphering the complexity of ligand-protein recognition pathways using supervised molecular dynamics (SuMD) simulations. J. Chem. Inf. Model 56, 687\u2013705 (2016).","journal-title":"J. Chem. Inf. Model"},{"key":"31652_CR141","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1016\/j.bmc.2015.03.039","volume":"23","author":"G Deganutti","year":"2015","unstructured":"Deganutti, G., Cuzzolin, A., Ciancetta, A. & Moro, S. Understanding allosteric interactions in G protein-coupled receptors using supervised molecular dynamics: a prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000. Bioorg. Med. Chem. 23, 4065\u20134071 (2015).","journal-title":"Bioorg. Med. Chem."},{"key":"31652_CR142","doi-asserted-by":"crossref","unstructured":"Deganutti, G. & Moro, S. Supporting the identification of novel fragment-based positive allosteric modulators using a supervised molecular dynamics approach: a retrospective analysis considering the human A2A adenosine receptor as a key example. Molecules 22, 818 (2017).","DOI":"10.3390\/molecules22050818"},{"key":"31652_CR143","doi-asserted-by":"crossref","unstructured":"Deganutti G., Salmaso V., Moro S. Could adenosine recognize its receptors with a stoichiometry other than 1:1? Mol Inform 37, e1800009 (2018).","DOI":"10.1002\/minf.201800009"},{"key":"31652_CR144","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/cmdc.201700200","volume":"12","author":"G Deganutti","year":"2017","unstructured":"Deganutti, G., Welihinda, A. & Moro, S. Comparison of the human A2A adenosine receptor recognition by adenosine and inosine: new insight from supervised molecular dynamics simulations. ChemMedChem 12, 1319\u20131326 (2017).","journal-title":"ChemMedChem"},{"key":"31652_CR145","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/ci400766b","volume":"54","author":"D Sabbadin","year":"2014","unstructured":"Sabbadin, D. & Moro, S. Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale. J. Chem. Inf. Model 54, 372\u2013376 (2014).","journal-title":"J. Chem. Inf. Model"},{"key":"31652_CR146","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.str.2017.02.009","volume":"25","author":"V Salmaso","year":"2017","unstructured":"Salmaso, V., Sturlese, M., Cuzzolin, A. & Moro, S. Exploring protein-peptide recognition pathways using a supervised molecular dynamics approach. Structure 25, 655\u2013662.e652 (2017).","journal-title":"Structure"},{"key":"31652_CR147","doi-asserted-by":"publisher","first-page":"054103","DOI":"10.1063\/1.2432340","volume":"126","author":"D Branduardi","year":"2007","unstructured":"Branduardi, D., Gervasio, F. L. & Parrinello, M. From A to B in free energy space. J. Chem. Phys. 126, 054103 (2007).","journal-title":"J. Chem. Phys."},{"key":"31652_CR148","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1073\/pnas.202427399","volume":"99","author":"A Laio","year":"2002","unstructured":"Laio, A. & Parrinello, M. Escaping free-energy minima. Proc. Natl Acad. Sci. USA 99, 12562\u201312566 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31652_CR149","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1021\/jp045424k","volume":"109","author":"A Laio","year":"2005","unstructured":"Laio, A., Rodriguez-Fortea, A., Gervasio, F. L., Ceccarelli, M. & Parrinello, M. Assessing the accuracy of metadynamics. J. Phys. Chem. B 109, 6714\u20136721 (2005).","journal-title":"J. Phys. Chem. B"},{"key":"31652_CR150","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cpc.2013.09.018","volume":"185","author":"GA Tribello","year":"2014","unstructured":"Tribello, G. A., Bonomi, M., Branduardi, D., Camilloni, C. & Bussi, G. PLUMED 2: New feathers for an old bird. Comput. Phys. Commun. 185, 604\u2013613 (2014).","journal-title":"Comput. Phys. Commun."},{"key":"31652_CR151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40203-017-0037-x","volume":"5","author":"G Deganutti","year":"2016","unstructured":"Deganutti, G. et al. Impact of protein\u2013ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics. Silico Pharm. 5, 16 (2016).","journal-title":"Silico Pharm."},{"key":"31652_CR152","doi-asserted-by":"publisher","first-page":"020603","DOI":"10.1103\/PhysRevLett.100.020603","volume":"100","author":"A Barducci","year":"2008","unstructured":"Barducci, A., Bussi, G. & Parrinello, M. Well-tempered metadynamics: a smoothly converging and tunable free-energy method. Phys. Rev. Lett. 100, 020603 (2008).","journal-title":"Phys. Rev. Lett."},{"key":"31652_CR153","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/jpet.106.113589","volume":"320","author":"JG Baker","year":"2007","unstructured":"Baker, J. G. & Hill, S. J. A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1 receptor. J. Pharm. Exp. Ther. 320, 218\u2013228 (2007).","journal-title":"J. Pharm. Exp. Ther."},{"key":"31652_CR154","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/sj.bjp.0705192","volume":"138","author":"SJ Hill","year":"2003","unstructured":"Hill, S. J. & Baker, J. G. The ups and downs of Gs- to Gi-protein switching. Br. J. Pharm. 138, 1188\u20131189 (2003).","journal-title":"Br. J. Pharm."},{"key":"31652_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10842","volume":"7","author":"C Klein Herenbrink","year":"2016","unstructured":"Klein Herenbrink, C. et al. The role of kinetic context in apparent biased agonism at GPCRs. Nat. Commun. 7, 10842 (2016).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31652-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:07:29Z","timestamp":1669295249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31652"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31652-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.04.023945","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Warwick has filed a patent application for uses of BnOCPA in which M.W. and B.G.F. are named as the inventors and M.Lo., R.H., G.L., D.Sp., C.A.R. and G.D. are named as contributors. F.Y.Z., H.F.W, and D.Sp. are employees and\/or hold shares in NeuroSolutions, which holds a licence to this patent. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4150"}}